Abstract
Site-selective protein–protein coupling has long been a goal of chemical biology research. In recent years, that goal has been realized to varying degrees through a number of techniques, including the use of tyrosinase-based coupling strategies. Early publications utilizing tyrosinase from Agaricus bisporus(abTYR) showed the potential to convert tyrosine residues into ortho-quinone functional groups, but this enzyme is challenging to produce recombinantly and suffers from some limitations in substrate scope. Initial screens of several tyrosinase candidates revealed that the tyrosinase from Bacillus megaterium (megaTYR) is an enzyme that possesses a broad substrate tolerance. We use the expanded substrate preference as a starting point for protein design experiments and show that single point mutants of megaTYR are capable of activating tyrosine residues in various sequence contexts. We leverage this new tool to enable the construction of protein trimers via a charge-directed sequential activation of tyrosine residues (CDSAT).
Graphical Abstract

INTRODUCTION
Site-selective post-translational modification of proteins has long been an object of study for both chemists and biologists. The augmentation of the native properties of these biomolecules to contain fluorophores,1,2 drug molecules,3 and other signaling moieties has been of tremendous value to both our understanding of biology and the creation of new therapeutics.3-6 While much work has been done in the attachment of small molecule cargoes, the facile attachment of additional whole proteins has proven more difficult. The primary challenge of protein–protein coupling lies in the steric inhibition that must be overcome in the joining of large molecules as well as the difficulty in the generation of suitable selective reaction handles due to the frequent occurrence of most native amino acids. Current methods for the site-selective synthesis of protein conjugates involve the introduction of uniquely reactive unnatural amino acids (UAAs) into the backbone sequence,7,8 maleimide-cysteine linkages,9 intein-based strategies,10 and enzymatic coupling reactions.6,11-14
Although these methods have addressed many important challenges in chemical biology, limitations still exist. The site selective incorporation of unnatural amino acids into proteins relies on stop codon repurposing, which requires special growth media and often lowers protein yield.7,8 Thiol-reactive cross-linkers, such as maleimides, are specific to cysteine residues on the protein surface that are rare enough to afford selectivity and can be readily inserted via single base mutagenesis. However, the maleimide reactive handle is challenging to install on the surface of full proteins.9 For many enzymatic coupling techniques, such as sortase, butelase, and farnesyltransferase, coupling can only occur at the N- and C-termini.6,11-14 More recent work has demonstrated that a combination of sortase and butelase can be used to sequentially conjugate multiple coupling partners onto a single protein.15 A similar method for synthesizing multiprotein conjugates was also developed that uses an asparaginyl endopeptidase instead of the butelase and sortase combination.16 Yet another approach to terminal protein ligation is the use of intein-based splicing which enables the facile combination of peptides and proteins through thioester intermediates.10,17 While powerful, these approaches are still limited to conjugation via N or C-termini, which limits the relative orientation of the conjugate. Most other coupling approaches such as SpyCatcher/SpyTag require the insertion of bulky recognition domains and pose additional risks of immunological rejection.18
Tyrosinases, a broadly distributed class of enzymes involved in the melanin synthesis pathway in every kingdom of life, provide promising new alternatives. Tyrosinase enzymes normally catalyze the oxidation of tyrosine to a dopaquinone intermediate, which then cyclizes to form dopachrome.19-23 Recent studies have repurposed the commercially available mushroom tyrosinase (abTYR) to catalyze site specific oxidative coupling reactions at N- and C-terminal tyrosine residues using different types of coupling partners. Strained alkynes24 and nucleophilic coupling partners, such as secondary amines,25 anilines,26 and surface exposed cysteine residues,27 have expanded the possible sites of enzymatic protein bioconjugation past the N- and C-termini. This methodology is versatile and can take place at temperatures ranging from 4 °C to room temperature and near-neutral pH to preserve the function of sensitive proteins.27
In spite of the recent success and convenience of abTYR, it is not without limitations. In a recent investigation, abTYR was unable to activate tyrosine residues at the C terminus of protein L, regardless of linker length.26 Both abTYR and protein L are over 100 kDa in mass and are negatively charged, suggesting that electrostatic repulsion and steric hindrance may be the factors preventing the activation of this particular substrate by abTYR.28,29 A smaller, 35.5 kDa tyrosinase from Bacillus megaterium (megaTYR, referred to as bmTYR in ref 26) was found to activate C-terminal tyrosines on protein L regardless of linker length.21,26 In this study, we characterize the substrate preferences of these tyrosinases and show that abTYR is unable to oxidize tyrosines in negatively charged substrates, whereas megaTYR and the recently reported tyrosinase from the archaeon, Candidatus Nitrosopumilus koreensis (cnkTYR),30 are much more promiscuous. In this report, we generate new versions of megaTYR selective for tyrosine residues in specific charge contexts. Moreover, we leverage this new tool to enable the construction of protein trimers via charge-directed sequential activation of tyrosine residues (CDSAT).
RESULTS AND DISCUSSION
In our search for more sequence permissive enzymes than abTYR (Figure 1A) we identified tyrosinases from Bacillus megaterium (megaTYR) and Candidatus Nitrosopumilus koreensis (cnkTYR) as optimal candidates for recombinant expression. These particular tyrosinases were chosen as they are both monomeric tyrosinases that have been shown to be easily expressible in E. coli.30,31 Moreover, megaTYR was selected because several previous studies showed that the enzyme tolerated point mutations while retaining high activity to free tyrosine.21,31,32 The published crystal structures for megaTYR were beneficial for protein engineering, as they allowed rational design of point mutants and facilitated computational analysis of the protein (Figure 1B).31 In contrast, cnkTYR was recently shown to have excellent monophenol monooxygenase activity and to tolerate low temperatures without significant loss in catalytic efficiency which posed an attractive candidate despite the lack of published crystal structure (homology model presented in Figure 1C).23,30
Figure 1.
Structure and activity of tyrosinase enzymes from eukaryotic, prokaryotic, and archaeal sources. (A) Protein structure for abTYR from Agaricius bisporus with acidic residues in red and basic residues in blue. PDB ID: 2Y9X. (B) Protein structure for megaTYR from Bacillus megaterium with acidic residues in red and basic residues in blue. PDB ID: 6EI4. (C) Protein structure for cnkTYR from Candidatus Nitrosopumilus koreensis with acidic residues in red and basic residues in blue. Structure was generated using the I-TASSER Web server. (D) Peptide reaction screen showing percent conversion of Y200C sfGFP with the indicated peptide. All reactions carried out at 150 μM Y200C sfGFP, 250 μM peptide, and 12 U/L equivalent of either abTyr (dark blue), megaTYR (blue), or cnkTyr (light blue) in 50 mM pH 6.5 phosphate buffer for 30 min before quench with 4 mM tropolone and analysis via ESI-TOF-MS. Deconvoluted data were analyzed on www.chartograph.com with percent conversion calculated as percentage of peak area for the modified vs unmodified samples. Asterisks indicate where negligible amounts of protein modification were detected.
In addition to the previously published work on protein L,26 the motivation for these explorations was the realization that abTYR was incapable of activating phenols attached to a single stranded DNA (ssDNA) substrate. In contrast, our first experiment with megaTYR showed significant levels of coupling between GFP and the phenol-DNA (Figure S1). This reaction occurs as two distinct steps: the initial activation of the phenol to the ortho-quinone followed by addition of the nucleophile. These results suggested that some aspect of the DNA substrate was preventing activation by abTYR but was tolerated by megaTYR (Figure S1). We reasoned that this was likely the high degree of negative charge on the nucleotide substrate.
We next examined the substrate preference of the new tyrosinases, specifically with respect to their charge and steric tolerance. A peptide library with tyrosine residues at their C-termini was obtained, shown in Supporting Information Table 1, which contained a variety of charged and neutral sequence elements. C-terminal tyrosine peptides were chosen as they most closely resemble the protein constructs previously shown to be effective substrates for the tyrosinase oxidation. Future studies will be needed to examine the substrate activation on internal tyrosine residues as previous studies have shown tyrosinase activity in unstructured peptide substrates.33,34 However, our previous work has shown that even highly exposed tyrosine residues in folded proteins are not readily targeted unless they are adjacent to the N- or C-terminal position.26,27 The peptides from the C-terminal library were coupled to Y200C GFP in 30 min reactions and analyzed via ESI-TOF MS to determine conversion to the modified peptide–protein conjugate. To ensure that peptide coupling was not biased by electrostatic interactions between GFP (pI = 6.2) and the peptides, control reactions were run on a p-aminophenylalanine modified MS2 capsid, which has a pI of 8.0. These reactions reached similar levels of modification (SI Figure S2). In a comparison of abTYR to the non-eukaryotic tyrosinases, it is readily apparent that abTYR is significantly more sensitive to negative charge (Figure 1D). In fact, abTYR shows no activity toward any peptide with 3 or more acidic residues adjacent to the terminal tyrosine. Also of note is the fact that megaTYR shows high activity toward all peptide substrates, with a drop in activity only in the case of the RRRRY peptide. These results supported the earlier challenge activating ssDNA substrates using abTYR and suggest that megaTYR may serve as a highly permissive tyrosine activator. One additional observation of this study was that cnkTYR samples showed no discernible pattern of substrate specificity. The structures of the three tyrosinases were compared to determine the origin of their selectivities, with cnkTyr represented by a homology model created using the I-TASSER server.29,30,35-38 abTYR is found as a protein complex and shows significant steric occlusion of the active sites (Figure 1A),29 while megaTYR and cnkTYR are monomeric and show a much more open active site (Figure 1B,C).30,35 Due to their more predictable behaviors and established crystal structures, we focused our work on megaTYR and abTYR in subsequent experiments. However, further exploration or engineering of cnkTyr could yield a more specific phenol monooxygenase capable of acting with higher precision.
In the interest of improving megaTYR for even broader activity, we performed an evolutionary conservation analysis of the megaTYR backbone in order to determine target positions for engineering. Using the ConSurf web server, the 100 closest nonredundant homologues of megaTYR were clustered and a multiple sequence alignment was prepared (Figure 2A).39-42 A normalized conservation score was calculated for each position using an empirical Bayesian methodology, which accounts for phylogenetic relationships between homologues in its construction of an evolutionary model.43 The evolutionary conservation was mapped onto the megaTYR structure and used to identify mutable anionic residues with low conservation scores (Figure 2B, Table S2). Position R209 was also chosen as a position of interest, despite its mild conservation, due to its established role in potentiating diphenolase activity and its proximity to the active site (Figure 2C).31 We also chose to study R280 as a more distal mutable cationic residue with a low conservation score (Table S2). Previously studied mutants at positions V218 and F197 were not further investigated, as their impact on megaTYR activity was not beneficial to our purpose of producing a more electrostatically targeted tyrosinase.21,32
Figure 2.
Evolutionary conservation of amino acids in megaTYR (bmTYR). (A) Multiple sequence alignment of megaTYR backbone to its six nearest homologues. Residues are colored by conservation score calculated by using the evolutionary rate of 100 sequence homologues on the ConSurf web server. Highly conserved copper-binding residues are marked with an asterisk. Engineering sites are indicated with orange triangles. (B) Conservation coloring mapped to the megaTYR structure. Bound substrate is colored in green (PDB ID: 4P6T).44 (C) Active site of megaTYR with conservation coloring, copper ions shown in gold. Variable residues R209 and D55 surrounding the highly conserved active site were selected as engineering targets to alter substrate scope.
The utility of modulating tyrosinase charge was explored in abTYR and megaTYR. Mutants of megaTYR identified from literature and the conservation screen were modeled in Maestro using the charge mapping tool from the Epik and MacroModel modules to calculate the surface potential for each of the proteins compared to a point charge placed 14 Å from the active site copper atoms (Figure 3A, Table S2). We reasoned that surface-exposed polar and ionic residues proximal to the active site may be attractive targets, as they would have larger effects on active site potential than more distal residues, and modeled them in a similar manner (Table S3). We found that abTYR monomers had a net potential of −4.4 V due to high numbers of acidic residues on their surfaces, corresponding to an isoelectric point (pI) of only 4.41. When the full active complex of abTYR is considered the net potential drops to −15.7 V.29 In contrast, megaTYR was shown to have a net potential of +4.4 V and a pI of 8.66, correlating well with the observed charge preference.35
Figure 3.
Electrostatic calculations on tyrosinase mutants. (A) Surface potential maps of abTYR and several megaTYR mutants with negative charge in red and positive charge in blue. (B) Table showing results of charge potential calculations for the various tyrosinase mutants. For each tyrosinase a point charge was placed 14 Å from the copper atoms within the active site and potential charge and pI were calculated using the Epik and Macromodel modules of Maestro developed by Schrödinger. Δ potential is calculated as the change in potential between the wild type and the listed mutant.
In accordance with our assumption that more proximal residues would have a larger impact on active site potential, we found that R209H had a potential of +3.0 V, a significant reduction compared to the wild type, whereas R280H has a much smaller impact on the electrostatics near the active site (Figure 3B, Table S2). Similarly, D55K had the largest impact on the active site potential among the D/E to K mutants, corresponding to a potential of +7.33 V. Because of this, we also chose to model D55R to compare the effects of mutating anionic residues to lysine or arginine. While D55K had a potential of +7.33 V, D55R showed a slightly more positive net potential of +7.5 V, due to the higher pKa of arginine (Figure 3B, Table S2).
On the basis of data from the conservation screen and potential modeling, we generated megaTYR with R209H, D55K, and D55R mutations (structures with residues highlighted in Figure 4A). After initial screening at a tyrosinase concentration of 5 U/mL, it was observed that R209H decreased the charge preference of megaTYR, while D55K and D55R were found to increase the preference for anionic substrates as shown by the higher level of modification with the EEEEY peptide (Figure 4B). To assess the degree of substrate preference, we ran competition assays containing the EEEEY and RRRRY peptides in equal concentrations. In these assays, abTYR only showed activity toward RRRRY, while R209H showed equal preference for the two (Figure 4C). Interestingly, wild type megaTYR showed a 90% preference for EEEEY, while the D55K mutant showed a 95% preference and D55R a surprising >99% preference for the anionic peptide (Figure 4C). As D55K experienced expression challenges and was not capable of complete substrate differentiation, we chose to focus on D55R as the higher performing mutant.
Figure 4.
Point mutants of megaTYR and their impact on substrate preference. (A) Structural comparison of abTYR vs megaTYR with locations of point mutations highlighted. R209 is shown in yellow, D55 in blue. Structures show acidic (Asp and Glu) residues in red and basic (Lys and Arg) residues in blue. (B) Comparison of reactivity of abTYR vs single mutants of megaTYR on peptides EEEEY and RRRRY. Reactions were run for 30 min at RT in 50 mM pH 6.5 phosphate buffer, 5 U/mL tyrosinase, 150 μM Y200C sfGFP and 250 μM peptide. Reactions were quenched with 4 mM tropolone. (C) Competition reactions between RRRRY and EEEEY peptides to assess substrate preference of tyrosinase mutants. Reactions were run for 30 min at RT in 50 mM pH 6.5 phosphate buffer, 5 U/mL tyrosinase, 150 μM Y200C sfGFP and 250 μM of each peptide (500 μM total peptide concentration) . Reactions were quenched with 4 mM tropolone. (D) Peptide reaction screen showing percent conversion of Y200C sfGFP with the indicated peptide. All reactions were run at 10 μM Y200C sfGFP, 250 μM peptide, and 12 U/mL equivalent of either wt megaTYR (blue), R209H megaTYR (dark blue), or D55R megaTYR (light blue) in 50 mM pH 6.5 phosphate buffer for 30 min before quenching with 4 mM tropolone and analysis via ESI-TOF-MS. Deconvoluted data were analyzed on www.chartograph.com with percent conversions calculated as percentage of peak area percentages for the modified vs unmodified species.
We then performed a full substrate screen on each megaTYR variant (wild type, R209H, and D55R) at the same concentration as the initial substrate screen (12 U/mL) and found that these mutations only had a significant effect on the enzymatic activity toward highly charged peptide substrates. Interestingly, D55R megaTYR exhibited low conversion for the RRRRY peptide but retained high levels of activity toward the less highly charged cationic peptides (Figure 4D). Generation of sequence-orthogonal tyrosinases could enable the facile creation of complex multidomain proteins by coupling anionic and cationic tagged subunits sequentially. This could be done in a manner similar to peptide synthesis but using entire proteins as building blocks. The controlled production of multiprotein polymers would be an enabling technology for protein based materials, biomedical technologies, and enzyme engineering.
Although the megaTYR mutants to date were not fully prevented from acting on cationic substrates, the range in selectivity between abTYR and D55R megaTYR proved a tantalizing target. To test this, the cysteine-containing Y200C sfGFP was modified with EEEEY and RRRRY C-terminal tags, which should be unreactive with abTYR and D55R megaTYR, respectively (Figures S3, S4). After purification, the Y200C sfGFP-EEEEY (Y200C GFP-E4Y) was exposed to abTYR for 30 min in a variety of conditions. Notably, the mushroom tyrosinase was able to append GGGGY and RRRRY peptides to the Y200C GFP-E4Y without oxidizing the EEEEY tag (Figures S3, S4). In addition, exposing the Y200C GFP-E4Y to abTYR resulted in no discernible oxidation by ESI-MS. This aligns with our previous peptide screens, and suggests that the EEEEY tag is not succeptible to abTYR activation (Figure S3). Similarly, Y200C sfGFP-RRRRY (Y200C GFP-R4Y) was exposed to D55R megaTYR under similar conditions, with the EEEEY peptide used in place of the RRRRY peptide. Similarly to abTYR, D55R megaTYR was able to selectively oxidize the added peptides without modifying the tyrosine tag on the Y200C GFP-R4Y. Reaction selectivity was further confirmed when exposure of Y200C GFP-R4Y to D55R megaTYR alone did not result in any oxidation (Figure S4). Together, these data suggest that abTYR and D55R megaTYR can be used for CDSAT on proteins and peptides.
To validate reaction orthogonality further, we next compared abTYR and maleimide mediated biotinylation of Y200C GFP-E4Y (Figure 5A-C). As a positive control, Y200C GFP-E4Y was selectively modified with maleimide biotin to generate biotinylated Y200C GFP-E4Y (Figure 5D). In parallel, we modified Y200C GFP-E4Y with a phenol-biotin in the presence of abTYR and showed selective oxidation of the small molecule to afford the Y200C GFP-E4Y-biotin conjugate (Figure 5E). After purification using a 10 kDa MWCO spin concentrator, both the maleimide and phenol GFP-E4Y-biotin were combined with Y200C sfGFP and 12 U/mL D55R megaTYR for 30 min and analyzed via ESI-TOFMS. We observed over 70% conversion to the trimer composed of two GFP proteins and a biotin molecule, making this one of the first techniques capable of creating 3-component fusions without the need for solid support tethering or removable protective groups (Figure 5F,G). In addition, some higher order modifications appeared, arising from residual disulfide formation between unreacted thiols in the first step. To combat the undesired formation of disulfide bonds between thiols in the protein coupling partner, we suggest pretreating these proteins with a 2x molar excess of TCEP in pH 7.0 Tris-HCl buffer, followed by an exchange into the reaction buffer via spin filtration. This pretreatment step was used for all subsequent reactions.
Figure 5.
Coupling of two proteins to a small molecule. (A) Scheme depicting the construction of a cysteine GFP (Y200C GFP), as well as a negative tyrosine tagged cysteine GFP (GFP E4Y). (B,C) ESI-MS data for unmodified Y200C GFP and GFP E4Y respectively. (D) ESI-MS of GFP E4Y modified with biotin maleimide. Biotin-maleimide coupled to GFP E4Y by combining 150 μM GFP E4Y with 500 μM biotin-maleimide at pH 7.5 for 2 h. (E) GFP E4Y was coupled to biotin-phenol by combining 150 μM GFP E4Y with 200 μM biotin-phenol with 12 U/mL abTYR in 50 mM phosphate pH 6.5 for 40 min at RT. Product mass expected = 29054 Da. (F,G) Reaction of 40 μM GFP-E4Y-biotin with 100 μM Y200C GFP with 12 U/mL megaTYR for 45 min at RT. Expected mass for GFP + GFP + maleimide biotin = 56446 Da and for GFP+GFP phenol = 56618 Da.
To evaluate the potential of an iterative tyrosinase approach for the creation of protein trimers, Y200C GFP-E4Y was combined with a MYGGS-tagged nanoluciferase and 20 U/mL abTYR to activate the neutral luciferase tag selectively (Figure 6A-C). Clean conversion to the Y200C GFP-E4Y-nanoluciferase dimer was observed, with no excess oxidation. To remove any unreacted starting material, the solution was purified using a 50 kDa MWCO spin concentrator (Figure 6C). As a third component, the thiol-containing S152CmCherry was added to the dimer solution with 20 U/mL D55R megaTYR to activate the EEEEY tag on the GFP. This strategy led to smooth conversion to the mCherry-GFPluciferase trimer (Figure 6D). We saw 100% conversion from the dimer to the final product, indicating that megaTYR is capable of catalyzing tyrosinase oxidation on anionic tags even in the presence of multiprotein complexes. The trifunctional nature of the construct identity was further validated by luminescence and fluorescence measurements. Upon introducing the nanoLuc substrate, FRET was observed between the luciferase, GFP, and mCherry subunits. In addition, direct excitation of the GFP fluorophore led to emission from the mCherry segment via energy transfer (Figure S5). This new capability to oxidize tyrosine residues in different charge contexts iteratively highlights the potential of this system to generate complex protein products for future applications.
Figure 6.
Use of tyrosinase charge selectivity for the synthesis of ternary protein complexes. (A) Reaction scheme showing the use of sequential reactions with abTYR and megaTYR to couple 3 proteins together. (B) Protein sequence maps for S152C mCherry (mCherry), Y200C GFP with EEEEY tag (GFP E4Y), and a MYGGS tagged nano Luciferase (nanoLuc). (C) Reaction of 120 μM GFP-E4Y with 200 μM nanoLuc and 20 U/mL abTYR for 1 h. GFP + nanoLuc structure shown above chart. Expected mass = 48,728 D) GFP E4Y-nanoLuc (10 μM) purified by spin down using a 50 kDa MWCO spin concentrator to a concentration of 50 μM and combined with 150 μM S152C mCherry and 20 U/mL D55R megaTYR for 1 h at RT converted E4Y GFP-nanoLuc to the mCherry-GFP-nanoLuc trimer after purification using 50 kDa MWCO spin filter. Trimer structure shown above spectrum. Expected mass = 76 153 Da.
Conclusion.
Here, we show that recombinantly expressed tyrosinases are successful activators of terminal tyrosine residues on a variety of protein and peptide substrates. The results from the megaTYR mutant screen show that bacterially derived tyrosinases possess sufficient selectivity to mediate protein–protein coupling reactions through tyrosine-cysteine bond formation and can be engineered to alter their substrate preferences. The success at modulating the charge preference of this enzyme indicates that it is tolerant toward mutation and can be engineered to achieve orthogonal reactivity preferences to those of abTYR. The result of these efforts is the ability to sequentially activate tyrosine residues based on their charge context, or CDSAT. The protein trimers created using CDSAT show that minimal engineering is required to produce a system capable of creating higher-order protein constructs while controlling their orientation via cyteine position. Such multivalent conjugates have tremendous potential for materials, therapeutic, and diagnostic applications.
Supplementary Material
ACKNOWLEDGMENTS
The authors thank the Zhang lab for making available the I-TASSER server: https://zhanglab.ccmb.med.umich.edu/I-TASSER/. The authors also thank Dr. Kathy Durkin and Dr. Dave Small and the MGCF Facility for providing computational resources for the electrostatics calculations. Computational work was supported by NIH Grant: S10OD023532. This work was supported by NIH Grant: R01 GM138693.
Footnotes
Supporting Information
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/jacs.1c03079.
(ZIP)
Experimental procedures, full mass spectra of key proteins before and after coupling, protein sequences, and other relevant data (PDF)
The authors declare the following competing financial interest(s): M.B.F is the Chair of the UC Berkeley Department of chemistry; a co-founder of Catena Biosciences; and a scientific adviser to Catena Biosciences. M.J.L is a co-founder of Catena Biosciences. The Regents of the University of California have patents pending for the use of tyrosinase in the manner described herein on which the authors are inventors.
Contributor Information
Casey S. Mogilevsky, Department of Chemistry, University of California, Berkeley, California 94720, United States.
Marco J. Lobba, Department of Chemistry, University of California, Berkeley, California 94720, United States.
Daniel D. Brauer, Department of Chemistry, University of California, Berkeley, California 94720, United States.
Alan M. Marmelstein, Department of Chemistry, University of California, Berkeley, California 94720, United States.
Johnathan C. Maza, Department of Chemistry, University of California, Berkeley, California 94720, United States.
Jamie M. Gleason, Department of Chemistry, University of California, Berkeley, California 94720, United States
Jennifer A. Doudna, Department of Chemistry, Department of Molecular and Cell Biology, and Howard Hughes Medical Institute, University of California, Berkeley, California 94720, United States; Gladstone Institutes, San Francisco, California 94158, United States; Innovative Genomics Institute, University of California, Berkeley, California 94720, United States
Matthew B. Francis, Department of Chemistry, University of California, Berkeley, California 94720, United States; Materials Sciences Division, Lawrence Berkeley National Laboratories, Berkeley, California 94720, United States.
REFERENCES
- (1).Zeng Y-S; Gao R-C; Wu T-W; Cho C; Tan K-T Fluorescent probe encapsulated in SNAP-Tag protein cavity to eliminate nonspecific fluorescence and increase detection sensitivity. Bioconjugate Chem. 2016, 27, 1872–1879. [DOI] [PubMed] [Google Scholar]
- (2).Gao J; Hori Y; Takeuchi O; Kikuchi K Live-Cell Imaging of Protein Degradation Utilizing Designed Protein-Tag Mutant and Fluorescent Probe with Turn-Off Switch. Bioconjugate Chem. 2020, 31, 577–583. [DOI] [PubMed] [Google Scholar]
- (3).Phillips GDL; Li G; Dugger DL; Crocker LM; Parsons KL; Mai E; Blättler WA; Lambert JM; Chari RV; Lutz RJ; et al. Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate. Cancer Res. 2008, 68, 9280–9290. [DOI] [PubMed] [Google Scholar]
- (4).Steen Redeker E; Ta DT; Cortens D; Billen B; Guedens W; Adriaensens P Protein engineering for directed immobilization. Bioconjugate Chem. 2013, 24, 1761–1777. [DOI] [PubMed] [Google Scholar]
- (5).Koo B; Dolan NS; Wucherer K; Munch HK; Francis MB Site-Selective Protein Immobilization on Polymeric Supports through N-Terminal Imidazolidinone Formation. Biomacromolecules 2019, 20, 3933–3939. [DOI] [PubMed] [Google Scholar]
- (6).Chen L; Cohen J; Song X; Zhao A; Ye Z; Feulner CJ; Doonan P; Somers W; Lin L; Chen PR Improved variants of SrtA for site-specific conjugation on antibodies and proteins with high efficiency. Sci. Rep 2016, 6, 1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (7).Khatwani SL; Kang JS; Mullen DG; Hast MA; Beese LS; Distefano MD; Taton TA Covalent protein-oligonucleotide conjugates by copper-free click reaction. Bioorg. Med. Chem 2012, 20, 4532–4539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (8).Horisawa K Specific and quantitative labeling of biomolecules using click chemistry. Front. Physiol 2014, 5, 457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (9).Ravasco JM; Faustino H; Trindade A; Gois PM Bioconjugation with maleimides: A useful tool for chemical biology. Chem. - Eur. J 2019, 25, 43–59. [DOI] [PubMed] [Google Scholar]
- (10).Shah NH; Muir TW Inteins: nature’s gift to protein chemists. Chemical science 2014, 5, 446–461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (11).Guimaraes CP; Witte MD; Theile CS; Bozkurt G; Kundrat L; Blom AE; Ploegh HL Site-specific C-terminal and internal loop labeling of proteins using sortase-mediated reactions. Nat. Protoc 2013, 8, 1787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (12).Nguyen GK; Kam A; Loo S; Jansson AE; Pan LX; Tam JP Butelase 1: a versatile ligase for peptide and protein macrocyclization. J. Am. Chem. Soc 2015, 137, 15398–15401. [DOI] [PubMed] [Google Scholar]
- (13).Nguyen GK; Qiu Y; Cao Y; Hemu X; Liu C-F; Tam JP Butelase-mediated cyclization and ligation of peptides and proteins. Nat. Protoc 2016, 11, 1977–1988. [DOI] [PubMed] [Google Scholar]
- (14).Blanden MJ; Suazo KF; Hildebrandt ER; Hardgrove DS; Patel M; Saunders WP; Distefano MD; Schmidt WK; Hougland JL Efficient farnesylation of an extended C-terminal C (x) 3X sequence motif expands the scope of the prenylated proteome. J. Biol. Chem 2018, 293, 2770–2785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (15).Harmand TJ; Bousbaine D; Chan A; Zhang X; Liu DR; Tam JP; Ploegh HL One-pot dual labeling of IgG 1 and preparation of C-to-C fusion proteins through a combination of sortase A and butelase 1. Bioconjugate Chem. 2018, 29, 3245–3249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (16).Rehm FB; Harmand TJ; Yap K; Durek T; Craik DJ; Ploegh HL Site-specific sequential protein labeling catalyzed by a single recombinant ligase. J. Am. Chem. Soc 2019, 141, 17388–17393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (17).Thompson RE; Muir TW Chemoenzymatic semisynthesis of proteins. Chem. Rev 2020, 120, 3051–3126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (18).Zakeri B; Fierer JO; Celik E; Chittock EC; Schwarz-Linek U; Moy VT; Howarth M Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proc. Natl. Acad. Sci. U. S. A 2012, 109, E690–E697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (19).Inlow JK Homology models of four Agaricus bisporus tyrosinases. Int. J. Biol. Macromol 2012, 50, 283–293. [DOI] [PubMed] [Google Scholar]
- (20).Iozumi K; Hoganson GE; Pennella R; Everett MA; Fuller BB Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes. J. Invest. Dermatol 1993, 100, 806–811. [DOI] [PubMed] [Google Scholar]
- (21).Kanteev M; Goldfeder M; Chojnacki M; Adir N; Fishman A The mechanism of copper uptake by tyrosinase from Bacillus megaterium. JBIC. JBIC, J. Biol. Inorg. Chem 2013, 18, 895–903. [DOI] [PubMed] [Google Scholar]
- (22).Bijelic A; Pretzler M; Molitor C; Zekiri F; Rompel A The structure of a plant tyrosinase from walnut leaves reveals the importance of “Substrate-Guiding Residues” for enzymatic specificity. Angew. Chem., Int. Ed 2015, 54, 14677–14680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (23).Kim H; Yeon YJ; Choi YR; Song W; Pack SP; Choi YS A cold-adapted tyrosinase with an abnormally high monophenolase/diphenolase activity ratio originating from the marine archaeon Candidatus Nitrosopumilus koreensis. Biotechnol. Lett 2016, 38, 1535–1542. [DOI] [PubMed] [Google Scholar]
- (24).Bruins JJ; Westphal AH; Albada B; Wagner K; Bartels L; Spits H; van Berkel WJ; van Delft FL Inducible, site-specific protein labeling by tyrosine oxidation-strain-promoted (4+ 2) cycloaddition. Bioconjugate Chem. 2017, 28, 1189–1193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (25).Maza JC; Bader VDL; Xiao L; Marmelstein AM; Brauer DD; ElSohly AM; Smith MJ; Krska SW; Parish CA; Francis MB Enzymatic Modification of N-Terminal Proline Residues Using Phenol Derivatives. J. Am. Chem. Soc 2019, 141, 3885–3892. [DOI] [PubMed] [Google Scholar]
- (26).Marmelstein AM; Lobba MJ; Mogilevsky CS; Maza JC; Brauer DD; Francis MB Tyrosinase-Mediated Oxidative Coupling of Tyrosine Tags on Peptides and Proteins. J. Am. Chem. Soc 2020, 142, 5078–5086. [DOI] [PubMed] [Google Scholar]
- (27).Lobba MJ; Fellmann C; Marmelstein AM; Maza JC; Kissman EN; Robinson SA; Staahl BT; Urnes C; Lew RJ; Mogilevsky CS; et al. Site-Specific Bioconjugation through Enzyme-Catalyzed Tyrosine-Cysteine Bond Formation. ACS Cent. Sci 2020, 6, 1564–1571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (28).Donaldson JM; Zer C; Avery KN; Bzymek KP; Horne DA; Williams JC Identification and grafting of a unique peptidebinding site in the Fab framework of monoclonal antibodies. Proc. Natl. Acad. Sci. U. S. A 2013, 110, 17456–17461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (29).Ismaya WT; Rozeboom HJ; Weijn A; Mes JJ; Fusetti F; Wichers HJ; Dijkstra BW Crystal structure of Agaricus bisporus mushroom tyrosinase: identity of the tetramer subunits and interaction with tropolone. Biochemistry 2011, 50, 5477–5486. [DOI] [PubMed] [Google Scholar]
- (30).Do H; Kang E; Yang B; Cha HJ; Choi YS A tyrosinase, mTyr-CNK, that is functionally available as a monophenol monooxygenase. Sci. Rep 2017, 7, 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (31).Ben-Yosef VS; Sendovski M; Fishman A Directed evolution of tyrosinase for enhanced monophenolase/diphenolase activity ratio. Enzyme Microb. Technol 2010, 47, 372–376. [Google Scholar]
- (32).Goldfeder M; Kanteev M; Adir N; Fishman A Influencing the monophenolase/diphenolase activity ratio in tyrosinase. Biochim. Biophys. Acta, Proteins Proteomics 2013, 1834, 629–633. [DOI] [PubMed] [Google Scholar]
- (33).Mattinen ML; Lantto R; Selinheimo E; Kruus K; Buchert J Oxidation of Peptides and Proteins by Trichoderma reesei and Agaricus bisporus Tyrosinases. J. Biotechnol 2008, 133, 395–402. [DOI] [PubMed] [Google Scholar]
- (34).Marumo K; Waite JH Optimization of Hydroxylation of Tyrosine and Tyrosine-Containing Peptides by Mushroom Tyrosinase. Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol 1986, 872, 98–103. [DOI] [PubMed] [Google Scholar]
- (35).Deri B; Kanteev M; Goldfeder M; Lecina D; Guallar V; Adir N; Fishman A The unravelling of the complex pattern of tyrosinase inhibition. Sci. Rep 2016, 6, 34993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (36).Roy A; Kucukural A; Zhang Y I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc 2010, 5, 725–738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (37).Zhang Y I-TASSER server for protein 3D structure prediction. BMC Bioinf. 2008, 9, 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (38).Yang J; Yan R; Roy A; Xu D; Poisson J; Zhang Y The I-TASSER Suite: protein structure and function prediction. Nat. Methods 2015, 12, 7–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (39).Glaser F; Pupko T; Paz I; Bell RE; Bechor-Shental D; Martz E; Ben-Tal N ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 2003, 19, 163–164. [DOI] [PubMed] [Google Scholar]
- (40).Landau M; Mayrose I; Rosenberg Y; Glaser F; Martz E; Pupko T; Ben-Tal N ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res. 2005, 33, W299–302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (41).Celniker G; Nimrod G; Ashkenazy H; Glaser F; Martz E; Mayrose I; Pupko T; Ben-Tal N ConSurf: Using Evolutionary Data to Raise Testable Hypotheses about Protein Function. Isr. J. Chem 2013, 53, 199–206. [Google Scholar]
- (42).Ashkenazy H; Erez E; Martz E; Pupko T; Ben-Tal N ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res. 2010, 38, W529–W533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (43).Ashkenazy H; Abadi S; Martz E; Chay O; Mayrose I; Pupko T; Ben-Tal N ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Research. Nucleic Acids Res. 2016, 44, W344–W350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (44).Goldfeder M; Kanteev M; Isaschar-Ovdat S; Adir N; Fishman A Determination of tyrosinase substrate-binding modes reveals mechanistic differences between type-3 copper proteins. Nat. Commun 2014, 5, 1–5. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






